Increased brain size and cellular content in infant rats treated with an opiate antagonist

Science (New York, N.Y.)
|September 16, 1983
PubMed

Insights

Naltrexone administration in early life stimulated significant increases in body and brain growth in rats. This suggests the endorphin and opiate receptor system plays a crucial role in developmental processes.

Area of Science:

  • Neuroscience
  • Developmental Biology
  • Pharmacology

Background:

  • The role of the endorphin and opiate receptor system in mammalian development is not fully understood.
  • Naltrexone is an opioid antagonist used to block the effects of opioids.

Purpose of the Study:

  • To investigate the effects of early-life naltrexone exposure on physical and neurological development in rats.
  • To explore the potential involvement of the endorphin and opiate system in growth regulation.

Main Methods:

  • Rat offspring were administered daily naltrexone injections from birth to day 21.
  • Body, brain, and cerebellar weights were measured.
  • Morphometric analysis of the cerebrum and cerebellum was performed.
  • Cellular composition of the cerebellum was assessed.

Main Results:

  • Naltrexone-injected rats showed increased body (18%), brain (11%), and cerebellar (5%) weights compared to controls.
  • Cerebral somatosensory cortex was 18% thicker in naltrexone-treated rats.
  • The cerebellum was 41% larger, with 70% more glial cells and 30% more granule neurons.
  • Prenatally derived neurons were unaffected.

Conclusions:

  • Early-life naltrexone administration promotes significant body and brain growth in rats.
  • These findings highlight a potential role for the endorphin and opiate receptor system in regulating development.
  • Naltrexone's growth-stimulating effects may offer insights into developmental disorders.

Related Concept Videos